17 beta-hydroxysteroid dehydrogenase 3 deficiency in the Mediterranean population
- PMID: 17551466
17 beta-hydroxysteroid dehydrogenase 3 deficiency in the Mediterranean population
Erratum in
- Pediatr Endocrinol Rev. 2007 Sep;5(1):470
Abstract
Eighty-five males with 17 beta-HSD3 were identified among a highly inbred Arab population in Israel and 57 studied over a period of 25 years. The founders of this defect originated in the mountainous regions of present Lebanon and Syria, but most of the families now live in Jerusalem, Hebron, the Tel-Aviv area and, in particular, in Gaza, where the frequency of affected males is estimated at 1 in 100 to 150. Affected individuals are born with ambiguity of the external genitalia and reared as females until puberty. Thereafter marked virilization occurs, leading in many cases to the spontaneous adoption of a male gender identity and role. Adults develop a male habitus with abundant body hair and beard and the phallus and testes enlarge to adult proportions. Gender reassignment in infancy was only possible when enough erectile tissue was present at birth and developed into a normal size penis with testosterone. 17 beta-HSD3 deficiency can be reliably diagnosed by endocrine evaluation and mutation analysis. In adults the defect is characterized by markedly increased concentrations of androstenedione (A) with borderline low to normal testosterone (T) levels and a high A/T ratio. 5a-dihydrotestosterone (DHT) concentrations are moderately decreased, normal or high and dehydroepiandrosterone (DHEA) levels are high. The estrogen pathway is also impaired, even though both estrone (E-1) and estradiol-17 beta (E-2) levels are high. Children have low basal levels of all androgens, but the defect may be demonstrated after prolonged stimulation with human chorionic gonadotropin (HCG). LH and FSH levels are very high after puberty and normal in childhood. 17 beta-HSD3 isozyme is encoded by the chromosome 9q22 17 beta-HSD3 gene and expressed exclusively in testes. A point mutation in exon 3, codon 80 of the 17 beta-HSD3 gene, R80Q, caused by a single base substitution from CGG ( arginine) to CAG ( glutamine) was identified in both alleles of 24 individuals from 9 extended Arab families from Gaza, Jerusalem and Lod-Ramle. Twenty-one homozygote males (46,XY) were MPH with testicular 17 beta-HSD3 deficiency whereas the three homozygote females (46,XX) were asymptomatic, had normal internal and external genitalia, normal sexual development and revealed no biochemical evidence of 17 beta-HSD3 deficiency. The molecular pattern is compatible with an autosomal recessive mode of inheritance, sex dependent.
Similar articles
-
Steroid 17β-hydroxysteroid dehydrogenase deficiency in man: an inherited form of male pseudohermaphroditism.J Steroid Biochem Mol Biol. 1992 Dec;43(8):989-1002. doi: 10.1016/0960-0760(92)90327-F. J Steroid Biochem Mol Biol. 1992. PMID: 22217844 Review.
-
A (R80Q) mutation in 17 beta-hydroxysteroid dehydrogenase type 3 gene among Arabs of Israel is associated with pseudohermaphroditism in males and normal asymptomatic females.J Clin Endocrinol Metab. 1996 May;81(5):1827-31. doi: 10.1210/jcem.81.5.8626842. J Clin Endocrinol Metab. 1996. PMID: 8626842
-
Male pseudohermaphroditism due to 17 beta-hydroxysteroid dehydrogenase deficiency: studies on the natural history of the defect and effect of androgens on gender role.J Steroid Biochem. 1983 Jul;19(1B):663-74. doi: 10.1016/0022-4731(83)90233-9. J Steroid Biochem. 1983. PMID: 6310248
-
Mechanisms of androgen production in male pseudohermaphroditism due to 17 beta-hydroxysteroid dehydrogenase deficiency.J Clin Endocrinol Metab. 1992 Sep;75(3):773-8. doi: 10.1210/jcem.75.3.1325474. J Clin Endocrinol Metab. 1992. PMID: 1325474
-
Androgens, androgen receptors, and male gender role behavior.Horm Behav. 2001 Sep;40(2):358-66. doi: 10.1006/hbeh.2001.1684. Horm Behav. 2001. PMID: 11534997 Review.
Cited by
-
A Novel Compound Heterozygous Mutation of HSD17B3 Gene Identified in a Patient With 46,XY Difference of Sexual Development.Sex Med. 2022 Aug;10(4):100522. doi: 10.1016/j.esxm.2022.100522. Epub 2022 May 17. Sex Med. 2022. PMID: 35588601 Free PMC article.
-
Detection of 46, XY Disorder of Sex Development (DSD) Based on Plasma Cell-Free DNA and Targeted Next-Generation Sequencing.Genes (Basel). 2021 Nov 25;12(12):1890. doi: 10.3390/genes12121890. Genes (Basel). 2021. PMID: 34946839 Free PMC article.
-
The laboratory in the multidisciplinary diagnosis of differences or disorders of sex development (DSD): III) Biochemical and genetic markers in the 46,XYIV) Proposals for the differential diagnosis of DSD.Adv Lab Med. 2021 Jul 5;2(4):494-515. doi: 10.1515/almed-2021-0043. eCollection 2021 Nov. Adv Lab Med. 2021. PMID: 37360892 Free PMC article. Review.
-
Guidance for shared decision-making regarding orchiectomy in individuals with differences of sex development due to 17-β-hydroxysteroid dehydrogenase type 3 deficiency.Front Pediatr. 2025 Feb 20;13:1549400. doi: 10.3389/fped.2025.1549400. eCollection 2025. Front Pediatr. 2025. PMID: 40051913 Free PMC article. Review.
-
Four novel mutations identification in 17 beta-hydroxysteroid dehydrogenase-3 deficiency and our clinical experience: possible benefits of early treatment.Front Endocrinol (Lausanne). 2024 Feb 15;14:1267967. doi: 10.3389/fendo.2023.1267967. eCollection 2023. Front Endocrinol (Lausanne). 2024. PMID: 38425490 Free PMC article.